Wusson Accelerator AB

Därför är det så svårt att hålla sig från snacksen

Okej alla gottegrisar, forskare vid Max Planck institutet och Yale påstår att om vi regelbundet mumsar i oss små mängder livsmedel med högt fett- och sockerinne...

Anna Törner: Yes, I Am Sick, But Not Weak

”People often say that someone who is ill only has one wish—to get better. But I think that is not true. Someone who is ill also longs to be understood, to be r...

A modular system for precise and automated cell dispensing

How the benefits of laboratory automation can be combined with gentle cell handling.

Danish biotech to buy struggling American oncology company

Danish drugmaker Pharmacosmos has agreed to acquire American pharmaceutical company G1 Therapeutics in a deal that amounts to 405 million dollars.

Optimize Courier SUPPLIERS (DISTRIBUTORS)

Ready-to-install solutions for the lab-on-a-chip

Design for manufacturing lab-on-a-chip devices Reducing time-to-market together

A new malaria vaccine offers hope but much more research is still needed

There has long been no vaccine against malaria, but there have been breakthroughs in recent years. However, it is still unclear how we become immune to the mala...

Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”

It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...

Optimize Your Visibility

ZEISS presents our newest VersaXRM® 730 3D X-ray microscope.

Italian pharmaceutical company buys rights to immunotherapy from Sanofi

Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).

Thomas Eldered: ”Innovation is the key”

Thomas Eldered speaks in a web clip about the challenges facing the life science sector in the future and what he, as an investor, finds most interesting in new companies.

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

A small thing that can solve your problems

If you are in need of a compact valve. Look no further! We have the VOVK

BD separerar affärsområdet Biosciences – fokuserar på medtech

BD slimmar portföljen och avyttrar affärsområdena bioscience och diagnostik. “Nya BD” ska bli ett helgjutet medicinteknikföretag.

Conference on Alzheimer’s reveals several advances in the field

In Gothenburg, Sweden, researchers and pharmaceutical companies from all over the world gathered to discuss one specific issue – neurological diseases. Life Sci...

Are you ready for EMC 2024?

Visit ZEISS at Europe’s largest Event dedicated to Microscopy and Imaging.

The US is leaving the WHO

The newly installed US President, Donald Trump, has issued an executive order for the US to leave the World Health Organization, WHO.

SMC lanserar ny elektrisk cylinder för livsmedelsindustrin

Nya HF2A-LEY är framtagen för att möta kraven inom livsmedelsindustrin och passar perfekt i maskiner som utsätts för regelbunden desinfektion och rengöring. Cyl...

Hajpat genterapibolag går för en spottstyver

Genterapibolaget Bluebird Bio värderades en gång till över 10 miljarder dollar – men säljs nu för en bråkdel av den summan.

Healthcare study: Alzheimer’s blood test shows high accuracy

A blood test for identifying Alzheimer’s has now been tested in the general healthcare setting. According to the researchers, the test was 90% accurate in making a diagnosis.

Från apotekare till poddare – Magnus Lejelöv har rösten som verktyg

Magnus Lejelöv har över 20 års erfarenhet från läkemedelssektorn och har intervjuat nära två hundra vårdprofiler i sina poddar. I maj står han på scenen i Lund ...

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.

Mavatar AB